Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Livio Brasili
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Concepts & Ideas
Living Beings
Anatomy
Chemicals & Drugs
Phenomena
Occupations
Sign-in to see full Profile
Network (preview)
22
Pigini, Maria
20
Quaglia, Wilma
19
Giannella, Mario
18
Melchiorre, Carlo
14
Angeli, Piero
13
Marucci, Gabriella
12
Giardinà, Dario
10
Bousquet, Pascal
10
Dontenwill, Monique
9
Piergentili, Alessandro
8
Franchini, Silvia
8
Gualtieri, Fulvio
6
Gentili, Francesco
6
Sorbi, Claudia
6
Strappaghetti, Giovannella
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Livio Brasili (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Brasili Livio; Donati Daniele; Mosti Luisa
The XIXth National Meeting on Medicinal Chemistry: Verona, Italy.
ChemMedChem 2009;4(6):899-904.
-
2009: Sorbi Claudia; Franchini Silvia; Tait Annalisa; Prandi Adolfo; Gallesi Rossella; Angeli Piero; Marucci Gabriella; Pirona Lorenza; Poggesi Elena; Brasili Livio
1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.
ChemMedChem 2009;4(3):393-9.
-
2009: Franchini Silvia; Tait Annalisa; Prandi Adolfo; Sorbi Claudia; Gallesi Rossella; Buccioni Michela; Marucci Gabriella; De Stefani Carla; Cilia Antonio; Brasili Livio
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a potent and selective 5-HT(1A) receptor agonist.
ChemMedChem 2009;4(2):196-203.
-
2005: Tait Annalisa; Luppi Amedeo; Franchini Silvia; Preziosi Elisa; Parenti Carlo; Buccioni Michela; Marucci Gabriella; Leonardi Amedeo; Poggesi Elena; Brasili Livio
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
Bioorganic & medicinal chemistry letters 2005;15(4):1185-8.
-
2005: Costantino Luca; Gandolfi Francesca; Sorbi Claudia; Franchini Silvia; Prezzavento Orazio; Vittorio Franco; Ronsisvalle Giuseppe; Leonardi Amedeo; Poggesi Elena; Brasili Livio
Synthesis and structure-activity relationships of 1-aralkyl-4-benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent sigma ligands.
Journal of medicinal chemistry 2005;48(1):266-73.
-
2004: Dupuy L; Urosevic D; Greney H; Quaglia W; Pigini M; Brasili L; Dontenwill M; Bousquet P
I1 imidazoline receptor-mediated effects on apoptotic processes in PC12 cells.
Cell death and differentiation 2004;11(9):1049-52.
-
2003: Gentili Francesco; Bousquet Pascal; Brasili Livio; Dontenwill Monique; Feldman Josiane; Ghelfi Francesca; Giannella Mario; Piergentili Alessandro; Quaglia Wilma; Pigini Maria
Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues.
Journal of medicinal chemistry 2003;46(11):2169-76.
-
2003: Brasili Livio; Sorbi Claudia; Franchini Silvia; Manicardi Massimo; Angeli Piero; Marucci Gabriella; Leonardi Amedeo; Poggesi Elena
1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.
Journal of medicinal chemistry 2003;46(8):1504-11.
-
2002: Gentili Francesco; Bousquet Pascal; Brasili Livio; Caretto Mariangela; Carrieri Antonio; Dontenwill Monique; Giannella Mario; Marucci Gabriella; Perfumi Marina; Piergentili Alessandro; Quaglia Wilma; Rascente Carla; Pigini Maria
Alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole.
Journal of medicinal chemistry 2002;45(1):32-40.
-
2001: Gulini U; Angeli P; Marucci G; Buccioni M; Giardinà D; Antolini L; Franchini S; Sorbi C; Brasili L
Synthesis, absolute configuration and antimuscarinic activity of the enantiomers of [1-(2,2-diphenyl-[1,3]dioxolan-4-yl)-ethyl]-dimethyl-amine.
Bioorganic & medicinal chemistry letters 2001;11(2):247-50.
-
2000: Greney H; Ronde P; Magnier C; Maranca F; Rascente C; Quaglia W; Giannella M; Pigini M; Brasili L; Lugnier C; Bousquet P; Dontenwill M
Coupling of I(1) imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline.
Molecular pharmacology 2000;57(6):1142-51.
-
2000: Pigini M; Quaglia W; Gentili F; Marucci G; Cantalamessa F; Franchini S; Sorbi C; Brasili L
Structure-activity relationship at alpha-adrenergic receptors within a series of imidazoline analogues of cirazoline.
Bioorganic & medicinal chemistry 2000;8(5):883-8.
-
2000: Brasili L
Enigmatic receptors.
Pharmaceutica acta Helvetiae 2000;74(2-3):201-3.
-
1999: Quaglia W; Bousquet P; Pigini M; Carotti A; Carrieri A; Dontenwill M; Gentili F; Giannella M; Maranca F; Piergentili A; Brasili L
2-(2-Phenylcyclopropyl)imidazolines: reversed enantioselective interaction at I(1) and I(2) imidazoline receptors.
Journal of medicinal chemistry 1999;42(15):2737-40.
-
1999: Pigini M; Bousquet P; Brasili L; Carrieri A; Dontenwill M; Gentili F; Giannella M; Leonetti F; Piergentili A; Quaglia W; Carotti A
Binding of tracizolines to the imidazoline receptor. Role of lipophilicity in quantitative structure-activity relationship models.
Annals of the New York Academy of Sciences 1999;881():118-22.
-
1999: Bruban V; Feldman J; Dontenwill M; Greney H; Brasili L; Giannella M; Pigini M; Bousquet P
An unexpected central hypertensive effect of the new imidazoline compound benazoline.
Annals of the New York Academy of Sciences 1999;881():102-5.
-
1998: Pigini M; Bousquet P; Brasili L; Carrieri A; Cavagna R; Dontenwill M; Gentili F; Giannella M; Leonetti F; Piergentili A; Quaglia W; Carotti A
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models.
Bioorganic & medicinal chemistry 1998;6(12):2245-60.
-
1998: Malmusi L; Franchini S; Mucci A; Schenetti L; Gulini U; Marucci G; Brasili L
Synthesis and antimuscarinic activity of some ether- and thioether-bearing 1,3-dioxolanes and related sulfoxides and sulfones.
Bioorganic & medicinal chemistry 1998;6(6):825-32.
-
1998: Quaglia W; Giannella M; Piergentili A; Pigini M; Brasili L; Di Toro R; Rossetti L; Spampinato S; Melchiorre C
1'-Benzyl-3,4-dihydrospiro[2H-1- benzothiopyran-2,4'-piperidine] (spipethiane), a potent and highly selective sigma1 ligand.
Journal of medicinal chemistry 1998;41(10):1557-60.
-
1997: Carrieri A; Brasili L; Leonetti F; Pigini M; Giannella M; Bousquet P; Carotti A
2-D and 3-D modeling of imidazoline receptor ligands: insights into pharmacophore.
Bioorganic & medicinal chemistry 1997;5(5):843-56.
-
1997: Pigini M; Bousquet P; Carotti A; Dontenwill M; Giannella M; Moriconi R; Piergentili A; Quaglia W; Tayebati S K; Brasili L
Imidazoline receptors: qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity.
Bioorganic & medicinal chemistry 1997;5(5):833-41.
-
1997: Angeli P; Brasili L; Cingolani M L; Marucci G; Piergentili A; Pigini M; Quaglia W
Synthesis and structure-activity relationship studies in a series of 2-substituted 1,3-dioxolanes modified at the cationic head.
Bioorganic & medicinal chemistry 1997;5(4):731-7.
-
1996: Malmusi L; Mucci A; Schenetti L; Gulini U; Marucci G; Brasili L
Synthesis, NMR spectroscopy study, and antimuscarinic activity of a series of 2-(acyloxymethyl)-1,3-dioxolanes.
Bioorganic & medicinal chemistry 1996;4(12):2071-80.
-
1995: Brasili L; Pigini M; Marucci G; Quaglia W; Malmusi L; Lanier S M; Lanier B
Separation of alpha-adrenergic and imidazoline/guanidinium receptive sites (IGRS) activity in a series of imidazoline analogues of cirazoline.
Bioorganic & medicinal chemistry 1995;3(11):1503-9.
-
1995: Brasili L; Pigini M; Ehrhardt J D; Molines A; Greney H; Bousquet P; Dontenwill M
Structure-affinity relationship of cirazoline derivatives for idazoxan imidazoline-specific sites in the human cerebral cortex and the rabbit kidney.
Annals of the New York Academy of Sciences 1995;763():149-52.
-
1994: Piergentili A; Quaglia W; Tayebati S K; Paparelli F; Malmusi L; Brasili L
Synthesis and muscarinic receptors affinity of a series of antagonist bivalent ligands.
Farmaco (Società chimica italiana : 1989) 1994;49(2):83-7.
-
1991: Angeli P; Brasili L; Cingolani M L; Marucci G; Pigini P; Tonnini M C
Pharmacological characterization of muscarinic receptor subtypes in rabbit isolated tissue preparations.
Journal of autonomic pharmacology 1991;11(5):315-21.
-
1990: Angeli P; Brasili L; Cantalamessa F; Marucci G; Wess J
Determination of muscarinic agonist potencies at M1 and M2 muscarinic receptors in a modified pithed rat preparation.
Naunyn-Schmiedeberg's archives of pharmacology 1990;342(6):625-9.
-
1989: Corsano S; Strappaghetti G; Di Domenico E; Brasili L; Picchio M T
Synthesis and Ca-antagonist activity of some benzhydryl derivatives.
Archiv der Pharmazie 1989;322(12):873-8.
-
1989: Melchiorre C; Quaglia W; Picchio M T; Giardinà D; Brasili L; Angeli P
Structure-activity relationships among methoctramine-related polymethylene tetraamines. Chain-length and substituent effects on M-2 muscarinic receptor blocking activity.
Journal of medicinal chemistry 1989;32(1):79-84.
-
1989: Giardinà D; Brasili L; Gregori M; Massi M; Picchio M T; Quaglia W; Melchiorre C
Structure-activity relationships in prazosin-related compounds. Effect of replacing a piperazine ring with an alkanediamine moiety on alpha 1-adrenoreceptor blocking activity.
Journal of medicinal chemistry 1989;32(1):50-5.
-
1988: Pigini M; Brasili L; Giannella M; Giardinà D; Gulini U; Quaglia W; Melchiorre C
Structure-activity relationships in 1,4-benzodioxan-related compounds. Investigation on the role of the dehydrodioxane ring on alpha 1-adrenoreceptor blocking activity.
Journal of medicinal chemistry 1988;31(12):2300-4.
-
1988: Romanelli M N; Gualtieri F; Valle G; Brasili L; Angeli P
Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides.
Journal of medicinal chemistry 1988;31(9):1703-8.
-
1988: Romanelli M N; Teodori E; Gualtieri F; Angeli P; Brasili L
Enantioselectivity of muscarinic antagonists. 2,2-Dicyclohexyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides and related 3-oxides.
Journal of medicinal chemistry 1988;31(9):1698-702.
-
1988: Quaglia W; Brasili L; Cristalli G; Giardinà D; Picchio M T; Melchiorre C
Structure-activity relationships among benextramine-related tetraamine disulfides. Chain length effect on alpha-adrenoreceptor blocking activity.
Journal of medicinal chemistry 1988;31(9):1861-6.
-
1988: Melchiorre C; Cassinelli A; Brasili L; Giardinà D; Gulini U; Quaglia W
Alpha-adrenoceptor occupancy by N,N-dimethyl-2-bromo-2-phenethylamine hydrobromide (DMPEA) in rat vas deferens.
European journal of pharmacology 1988;153(2-3):255-61.
-
1988: Angeli P; Brasili L; Giannella M; Gualtieri F; Picchio M T; Teodori E
Chiral muscarinic agonists possessing a 1,3-oxathiolane nucleus: enantio- and tissue-selectivity on isolated preparations of guinea-pig ileum and atria and of rat urinary bladder.
Naunyn-Schmiedeberg's archives of pharmacology 1988;337(3):241-5.
-
1988: Corsano S; Strappaghetti G; Brasili L
Synthesis and pharmacological evaluation of some analogues of the Ca-antagonist cinnarizine.
Archiv der Pharmazie 1988;321(3):171-4.
-
1987: Brasili L; Cantalamessa F; Picchio M T; Quaglia W
Fluoronorepinephrines: further pharmacological evaluation in vitro and in pithed rats.
European journal of pharmacology 1987;144(2):141-6.
-
1987: Teodori E; Gualtieri F; Angeli P; Brasili L; Giannella M
Resolution, absolute configuration, and cholinergic enantioselectivity of (-)- and (+)-c-2-methyl-r-5-[(dimethylamino)methyl]-1,3-oxathiolane t-3-oxide methiodide and related sulfones.
Journal of medicinal chemistry 1987;30(10):1934-8.
-
1986: Strappaghetti G; Brasili L
Synthesis and pharmacological evaluation of cyclic and opened thioanalogues of piperoxan.
Il Farmaco; edizione scientifica 1986;41(10):794-800.
-
1986: Teodori E; Gualtieri F; Angeli P; Brasili L; Giannella M; Pigini M
Resolution, absolute configuration, and cholinergic enantioselectivity of (+)- and (-)-cis-2-methyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodide.
Journal of medicinal chemistry 1986;29(9):1610-5.
-
1986: Massi M; Venturi F; Brasili L; Melchiorre C
Hypotensive effect in dogs and rats of intravenous injections of the alpha 1-adrenoreceptor antagonist benoxathian.
Pharmacological research communications 1986;18(9):813-29.
-
1986: Brasili L; Cassinelli A; Angeli P; Melchiorre C
Thiol group may be involved in the irreversible blockade of presynaptic alpha 2-adrenoreceptors by pyrextramine and benextramine in the isolated guinea pig ileum.
Life sciences 1986;38(18):1633-40.
-
1985: Angeli P; Brasili L; Brancia E; Giardinà D; Quaglia W; Melchiorre C
Structure-activity relationships among benextramine-related tetraamine disulfides at peripheral alpha-adrenoreceptors.
Journal of medicinal chemistry 1985;28(11):1643-7.
-
1985: Giardinà D; Bertini R; Brancia E; Brasili L; Melchiorre C
Structure-activity relationships for prazosin and WB 4101 analogues as alpha 1-adrenoreceptor antagonists.
Journal of medicinal chemistry 1985;28(9):1354-7.
-
1985: Angeli P; Brasili L; Giannella M; Gualtieri F; Pigini M
Affinity and efficacy correlate with chemical structure more than potency does in a series of pentatomic cyclic muscarinic agonists.
British journal of pharmacology 1985;85(4):783-6.
-
1984: Melchiorre C; Brasili L; Giardinà D; Pigini M; Strappaghetti G
2-[[[2-(2,6-Dimethoxyphenoxy)ethyl]amino]-methyl] -1,4-benzoxathian: a new antagonist with high potency and selectivity toward alpha 1-adrenoreceptors.
Journal of medicinal chemistry 1984;27(12):1535-6.
-
1984: Brasili L; Angeli P; Brancia E; Melchiorre C
N,N''-(dithio-2,1-ethanediyl)bis[N'-(pyrrol-2-ylmethyl)-1, 6,- hexanediamine] (pyrextramine), a new irreversible alpha 1-adrenoreceptor blocking agent of the tetramine disulfide class.
European journal of pharmacology 1984;103(1-2):181-4.
-
1984: Castagnino E; Strappaghetti G; Corsano S; Gallucci P; Brasili L; Giardinà D
Synthesis and pharmacological evaluation of some WB4101 analogues bearing a naphthodioxanic nucleus.
Il Farmaco; edizione scientifica 1984;39(7):569-74.
-
1983: Castagnino E; Corsano S; Strappaghetti G; Brasili L; Gallucci P
Synthesis and pharmacological evaluation of propranolol-cyclic analogues.
Il Farmaco; edizione scientifica 1983;38(9):679-85.
-
1982: Melchiorre C; Giardinà D; Gallucci P; Brasili L
Structural requirements for competitive alpha-adrenoceptor occupancy by cyclic and opened analogues of WB 4101.
The Journal of pharmacy and pharmacology 1982;34(10):683-4.
-
1982: Gualtieri F; Brasili L; Giannella M; Pigini M
Molecular requirements of the active sites of the cholinergic receptors. XIX-Size evaluation of the muscarinic subsite.
Il Farmaco; edizione scientifica 1982;37(9):618-26.
-
1982: Brasili L; Leonelli M; Giannella M
Molecular requirements of the active sites of the cholinergic receptors. XVIII-Correlation between activity and double bond position among cyclopentene derivatives.
Il Farmaco; edizione scientifica 1982;37(7):431-7.
-
1981: Angeli P; Brasili L; Giardinà D; Melchiorre C
Molecular requirements of the active site of cholinergic receptors XV: Synthesis and biological activity of 2,3-dehydrodeoxamuscarone and 2,3-dehydrodeoxamuscarines.
Journal of pharmaceutical sciences 1981;70(5):489-92.
-
1981: Pigini M; Brasili L
Molecular requirements of the active sites of the cholinergic receptors. XVI - Synthesis and cholinergic activity of 2- or 5-alkyl or 5-phenyl-4-methyl-3-oxo-1-dimethylaminomethylcyclopentane methiodide.
Il Farmaco; edizione scientifica 1981;36(2):152-8.
-
1980: Brasili L; Melchiorre C; Belleau B; Benfey B G
Reactivation by cysteamine of vascular alpha adrenoceptors blocked by the tetramine disulfide benextramine and interaction of benextramine with phenoxybenzamine.
Canadian journal of physiology and pharmacology 1980;58(12):1490-3.
-
1980: Benfey B G; Belleau B; Brasili L; Giannella M; Melchiorre C
Irreversible alpha adrenoceptor blocking effects and reversible muscarinic blocking and nicotinic blocking effects of tetramine disulfides on the heart.
Canadian journal of physiology and pharmacology 1980;58(12):1477-83.
-
1980: Benfey B G; Brasili L; Melchiorre C; Belleau B
Potentiation and inhibition of nicotinic effects on striated muscle by the tetramine disulfide benextramine.
Canadian journal of physiology and pharmacology 1980;58(8):984-8.
-
1980: Giannella M; Angeli P; Melchiorre C; Brasili L
Molecular requirements of the active sites of the cholinergic receptors. XII - 3-Methyl-2-oxo-1-dimethylaminomethylcyclopentane methiodide as a new selective agonist for the nicotinic receptor.
Il Farmaco; edizione scientifica 1980;35(4):253-62.
-
1980: Pigini M; Ballini R; Gualtieri F; Brasili L
Molecular requirements of the active sites of the cholinergic receptors. XI - Synthesis and biological evaluation of isomuscarie and its isomers.
Il Farmaco; edizione scientifica 1980;35(3):167-80.
Sign-in to see more